Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
17,917,908
-
Share change
-
-775,112
-
Total reported value
-
$6,609,367,034
-
Put/Call ratio
-
269%
-
Price per share
-
$368.97
-
Number of holders
-
415
-
Value change
-
-$267,830,891
-
Number of buys
-
191
-
Number of sells
-
186
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2015
As of 30 Jun 2015 ISHARES TR - ISHARES BIOTECH (IBB) had 415 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,917,908 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, UBS Group AG, MANAGED ACCOUNT ADVISORS LLC, CHURCHILL MANAGEMENT Corp, and SG Americas Securities, LLC.
This table shows 415 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.